Table 3.

Differences between serum FA-ceramide (CER) (nmol/ml) concentrations in study group and reference group

Ceramide (FA)	Study group M (Q1-Q3)	Reference group M (Q1-Q3)	p value
CER myristic (C14:0)	2.1 (1.4–4.3)	0.9 (0.7–1.2)	< 0.001
CER palmitic (C16:0)	8.6 (6.7–10.4)	5.2 (4.8–6.8)	< 0.001
CER palmitoleic (C16:1)	1.0 (0.8–1.3)	0.6 (0.5–0.8)	< 0.001
CER stearic (C18:0)	5.6 (4.5–7.6)	4.0 (3.6–4.5)	< 0.005
CER oleic (C18:1)	2.8 (2.4–3.6)	2.1 (1.9–2.8)	< 0.005
CER linoleic (C18:2)	0.3 (0.0–1.0)	0.2 (0.0–0.7)	ns
CER arachidic (C20:0)	0.5 (0.4–0.6)	0.4 (0.4–0.5)	ns
CER linolenic (C18:3)	0.3 (0.2–0.3)	0.2 (0.2–0.3)	ns
CER behenic (C22:0)	1.5 (1.3–1.7)	1.3 (1.1–1.4)	< 0.01
CER arachidonic (C20:4)	0.5 (0.4–0.7)	0.5 (0.4–0.7)	ns
CER lignoceric (C24:0)	3.3 (2.8–4.1)	3.0 (2.6–3.3)	< 0.05
CER eicosapentaenoic (C20:5)	0.8 (0.7–0.9)	0.8 (0.7–0.9)	ns
CER nervinic (C24:1)	2.3 (2.0–2.6)	2.0 (1.9–2.2)	ns
CER docosahexaenoic (C22:6)	0.7 (0.6–0.9)	0.7 (0.6–0.8)	ns